Axonics Income from Continuous Operations 2017-2024 | AXNX

Axonics income from continuous operations from 2017 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Axonics Annual Income from Continuous Operations
(Millions of US $)
2023 $-6
2022 $-60
2021 $-80
2020 $-55
2019 $-80
2018 $-32
2017 $-18
2016 $-17
Axonics Quarterly Income from Continuous Operations
(Millions of US $)
2024-06-30 $7
2024-03-31 $-19
2023-12-31 $7
2023-09-30 $4
2023-06-30 $-7
2023-03-31 $-9
2022-12-31 $1
2022-09-30 $-16
2022-06-30 $-21
2022-03-31 $-23
2021-12-31 $-15
2021-09-30 $-17
2021-06-30 $-25
2021-03-31 $-23
2020-12-31 $-11
2020-09-30 $-9
2020-06-30 $-20
2020-03-31 $-15
2019-12-31 $-23
2019-09-30 $-25
2019-06-30 $-19
2019-03-31 $-13
2018-12-31 $-10
2018-09-30 $-8
2018-06-30 $-9
2018-03-31 $-7
2017-12-31
2017-09-30 $-5
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $3.600B $0.366B
Axonics Modulation Technologies Inc. is focused on development and commercialization of a novel implantable SNM system for patients with urinary and bowel dysfunction and disrupting the SNM market. Axonics Modulation Technologies Inc. is based in Irvine, CA.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $11.384B 0.00
Inspire Medical Systems (INSP) United States $5.892B 183.76
Hims & Hers Health (HIMS) United States $5.028B 130.06
IRhythm Technologies (IRTC) United States $2.707B 0.00
Enovis (ENOV) United States $2.594B 17.58
Privia Health (PRVA) United States $2.547B 213.00
Omnicell (OMCL) United States $2.306B 75.97
Azenta (AZTA) United States $2.190B 124.39
10x Genomics (TXG) United States $1.893B 0.00
Clover Health Investments (CLOV) United States $1.696B 0.00
Schrodinger (SDGR) United States $1.365B 0.00
Phreesia (PHR) United States $1.228B 0.00
Standard BioTools (LAB) United States $0.800B 0.00
Fulgent Genetics (FLGT) United States $0.589B 0.00
Butterfly Network (BFLY) United States $0.558B 0.00
Talkspace (TALK) United States $0.555B 0.00
Definitive Healthcare (DH) United States $0.500B 84.80
Health Catalyst (HCAT) United States $0.498B 0.00
Pulmonx (LUNG) United States $0.294B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.230B 0.00
TruBridge (TBRG) United States $0.203B 58.91
American Well (AMWL) United States $0.135B 0.00
P3 Health Partners (PIII) United States $0.134B 0.00
EUDA Health Holdings (EUDA) Singapore $0.108B 0.00
HeartBeam (BEAT) United States $0.068B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
111 (YI) China $0.059B 0.00
Zepp Health (ZEPP) China $0.049B 0.00
SHL Telemedicine (SHLT) Israel $0.045B 0.00
CareCloud (CCLD) United States $0.044B 0.00
Outset Medical (OM) United States $0.040B 0.00
Movano (MOVE) United States $0.029B 0.00
Bullfrog AI Holdings (BFRG) United States $0.021B 0.00
MSP Recovery (LIFW) United States $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00